Publications

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

AuthID
P-00Q-V7X

Author(s)

Forschner, A

Battke, F

Hadaschik, D

Schulze, M

Weissgraeber, S

Han, CT

Kopp, M

Frick, M

Klumpp, B

Tietze, N

Amaral, T

Martus, P

Sinnberg, T

Eigentler, T

Kelm, U

Garbe, C

Doecker, D

Biskup, S

Document Type

Article

Year published

2019

Published

in JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN: 2051-1426

Volume: 7, Issue: 1

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1186/s40425-019-0659-0

Pubmed: 31300034

Scopus: 2-s2.0-85068916315

Wos: WOS:000475646900004

Source Identifiers

ISSN: 2051-1426

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

Useful Links

Get Help